Status:
TERMINATED
Secondary Intention Wound Healing Versus Micrografting in Patients Undergoing Mohs Surgery
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Momelan Technologies
Conditions:
Impaired Wound Healing
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
This study evaluates a novel micrografting technique to see how it will influence the healing rate and cosmetic result of second intention wounds. The graft harvesting and micrografting process was de...
Detailed Description
Participants with a scalp wound s/p Mohs procedure will be randomized to a micrografting technique intervention or to no intervention/heal with secondary intention alone (control). Intervention consis...
Eligibility Criteria
Inclusion
- Between 40-75 years old
- Status post Mohs procedure on the scalp with a wound that would otherwise be allowed to heal by second intention
- Superficial would-at deepest of 2.0 mm or to superficial fat, but not deep to muscle
- Area is less then 6 cm2 (wound diameter less than 2cm)
Exclusion
- Female patients who are breastfeeding, pregnant, or planning to become pregnant
- Abnormal bleeding observed during initial Mohs procedure that would suggest a higher risk of post-operative bleeding
- Subjects currently on immunosuppressive medications, chemotherapy or a cytotoxic agent
- Participation in another interventional study with potential exposure to an investigational drug within past 30 days or planned study entry within 90 days after study entrance
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01442844
Start Date
September 1 2011
End Date
May 1 2013
Last Update
July 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mgh Curtis
Boston, Massachusetts, United States, 02114